https://www.fic.nih.gov/News/GlobalHealthMatters/may-june-2020/Pages/fogarty-community-covid-response.aspx#aguilar

This short course aims to provide academic staff, students, researchers, reviewers and editors with the understanding of the global health within the African context and beyond.

https://afrehealth.org/resource/announcements/short-course-introduction-to-global-health

As a pan-African interdisciplinary health professionals’ organization, AFREhealth values diversity, and the principles of human rights. AFREhealth is committed to openness and diversity that is built on dignity and mutual respect for all members, participants, staff, and communities that we serve. We are committed to a world free of discrimination based on personal attributes including race, ethnicity, citizenship, age, religion, wealth, disability, sexual orientation, gender, and gender identity or expression.

Read More>>

Despite a lack of trials demonstrating the efficacy of chloroquine or hydroxychloroquine for the treatment of COVID-19, promotion and use of the two treatments has led to shortages, self-treatment and fatal overdoses, according to a perspective published in The American Journal of Tropical Medicine and Hygiene. The perspective suggests that African countries “strongly consider” putting prescription monitoring programs in place to ensure that off-label use of chloroquine and hydroxychloroquine is appropriate and beneficial for the treatment of COVID-19.

Safety issues regarding the use of chloroquine and hydroxychloroquine — as well as other “substandard and falsified medical products” — and related matters, including shortages and inflated pricing, put all countries at risk, but the potential issues may pose an especially large threat to Africa because of limitations specific to the continent’s health care system, according to the perspective.

Read More...